SCHEMBL18921930

SCHEMBL18921930

CPn1nc(C)c2cc(-c3cccc(NC4CCN(C)CC4)c3)cnc21

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 1/20 0.41
▸ TLR9 Q9NR96 1/20 0.40
▸ TLR7 Q9NYK1 1/20 0.40
▸ AXL P30530 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.35
▸ IDH2 P48735 1/20 0.35
▸ BRD4 O60885 3/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ DYRK1A Q13627 3/20 0.35
▸ DYRK1B Q9Y463 1/20 0.35
▸ GSK3B P49841 2/20 0.35
▸ HDAC1 Q13547 1/20 0.34
▸ WEE1 P30291 1/20 0.34
▸ EHMT2 Q96KQ7 1/20 0.34
▸ EHMT1 Q9H9B1 1/20 0.34
▸ ERN1 O75460 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18921924 0.82 CCNT1 (0.42) PIM1DYRK1AGSK3B
SCHEMBL12821587 0.79 AXL (0.47) HTR6TLR9TLR7AXLKDM4E
SCHEMBL12814012 0.79 TLR7 (0.42) TLR9TLR7KDM4E
SCHEMBL18921922 0.76 NMT1 (0.48) —
SCHEMBL18921935 0.68 MMP3 (0.41) GSK3B
SCHEMBL14887066 0.67 CYP1A2 (0.43) TLR7BRD4
SCHEMBL14887067 0.67 DYRK1A (0.47) BRD4DYRK1AGSK3B
SCHEMBL15829966 0.67 POLB (0.54) HTR6KDM4EIDH2POLB
SCHEMBL12821726 0.66 MAP3K11 (0.43) TLR9TLR7AXLKDM4EEHMT2
SCHEMBL13844240 0.66 KDM4E (0.71) HTR6KDM4EIDH2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9962382-B2 Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors ARRIEN PHARMACEUTICALS LLC (US) 2018-05-08 — — US disclosed
US-9669028-B2 Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors ARRIEN PHARMACEUTICALS LLC (US) 2017-06-06 — — US disclosed
Send feedback